Ji Jiang
Impact in
-
- Anesthesia and Sedative Agents
- Pharmacology top 2%
Papers in
-
- Cancer therapeutics and mechanisms 11
- Oncology 30
- Lung Cancer Research Studies 10
- Co-authors
- Pei Hu (127 shared papers)Qian Zhao (44 shared papers)Dongyang Liu (34 shared papers)Hongyun Wang (19 shared papers)Hongyun Wang (15 shared papers)Sheng Feng (5 shared papers)Jing Lu (2 shared papers)Wen Zhong (14 shared papers)
- Journals
- Journal of Chromatography B (18 papers)Journal of Pharmaceutical and Biomedical Analysis (13 papers)Bioanalysis (10 papers)Biomedical Chromatography (8 papers)The Journal of Clinical Pharmacology (6 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Ji Jiang
192 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 124
- Anesthesiology and Pain Medicine 110
- Pharmacology 181
- Analytical Chemistry 194
- Reproductive Medicine 120
- Oncology 364
Countries citing papers authored by Ji Jiang
This map shows the geographic impact of Ji Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji Jiang more than expected).
Fields of papers citing papers by Ji Jiang
This network shows the impact of papers produced by Ji Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji Jiang. The network helps show where Ji Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ji Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 197 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 220 | |
| 2 | 2020 | 84 | |
| 3 | 2016 | 70 | |
| 4 | 2018 | 65 | |
| 5 | 2004 | 57 | |
| 6 | 2008 | 50 | |
| 7 | 2009 | 49 | |
| 8 | 2018 | 49 | |
| 9 | 2012 | 48 | |
| 10 | 2016 | 43 | |
| 11 | 2002 | 40 | |
| 12 | 2010 | 40 | |
| 13 | 2017 | 33 | |
| 14 | Phase I trial of icotinib, a novel epidermal growth factor receptor tyrosine kinase inhibitor, in Chinese patients with non-small cell lung cancer. | 2011 | 31 |
| 15 | 2009 | 30 | |
| 16 | 2004 | 29 | |
| 17 | 2012 | 28 | |
| 18 | 2010 | 28 | |
| 19 | 2018 | 28 | |
| 20 | 2012 | 27 |
About Ji Jiang
Ji Jiang is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Analytical Chemistry and Pharmacology, having authored 197 papers that have together received 2.3k indexed citations. Recurring topics across this work include Analytical Methods in Pharmaceuticals (16 papers), Lung Cancer Treatments and Mutations (14 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers), Analytical Chemistry and Chromatography (13 papers), Cancer therapeutics and mechanisms (11 papers), Lung Cancer Research Studies (10 papers), Pharmacogenetics and Drug Metabolism (10 papers) and Diabetes Treatment and Management (10 papers). The work is most often cited by research in Anesthesiology and Pain Medicine (110 citations), Pharmacology (181 citations), Analytical Chemistry (194 citations), Reproductive Medicine (120 citations) and Oncology (364 citations). Ji Jiang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Pei Hu, Qian Zhao, Dongyang Liu, Hongyun Wang, Hongyun Wang, Sheng Feng, Jing Lu, Wen Zhong, Xia Chen and Fenlai Tan. Their work appears in journals such as Journal of Chromatography B, Journal of Pharmaceutical and Biomedical Analysis, Bioanalysis, Biomedical Chromatography and The Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.